1 completed, 1 withdrawn. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 1, Withdrawn 1 |
| Phase 2 | 1 | Withdrawn 1 |
Follow Invasive Pulmonary Aspergillosis: new trials by email Literature Review of Invasive Pulmonary Aspergillosis trials Research Report on Invasive Pulmonary Aspergillosis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Nebulised Liposomal Amphotericin for Invasive Pulmonary Aspergillosis (NAIFI01 Study) Amphotericin B Liposomal 50 MG, Placebo - Invasive Pulmonary Aspergillosis | Phase 1 | Completed | Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal | 13 | 2019-10-18 | 2023-06-15 |
| Study on Safety and Pharmacokinetics of Intravenous F901318 for Fungal Prophylaxis in AML Patients F901318, Caspofungin - Pulmonary Aspergillosis - Invasive, Acute Myeloid Leukemia | Phase 1 / Phase 2 | Withdrawn | F2G Ltd | 2017-04-20 | 2018-02-15 |
Aspergillosis (2) · Bacterial Infections and Mycoses (2) · Infections (2) · Invasive Fungal Infections (2) · Lung Diseases (2) · Lung Diseases, Fungal (2) · Mycoses (2) · Pulmonary Aspergillosis (2) · Respiratory Tract Diseases (2) · Hematologic Diseases (1) · Hemic and Lymphatic Diseases (1) · Leukemia (1) · Leukemia, Myeloid (1) · Neoplasms (1) · Neoplasms by Histologic Type (1)
Amphotericin B (1) · Caspofungin (1) · liposomal amphotericin B (1) · olorofim (1)
F2G Ltd (1) · Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal (1)
Spain (1)
Oliver Cornely, PhD, MD (1) · Sonsoles Sancho (1)